ライフサイエンスコーパス: virus antigen

1 d delayed-type hypersensitivity responses to virus antigen.

2 (IFN-y) on reencountering the same influenza virus antigen.

3 method for real-time detection of the Ebola virus antigen.

4 piratory syndrome coronavirus 2 (SARS-CoV-2) virus antigen.

5 specificity for the detection of Hepatitis B virus antigen.

6 with the memory response stimulated by pH1N1 virus antigen.

7 r cutaneous vaccine delivery using influenza virus antigen.

8 to their content of hemagglutinin, the major virus antigen.

9 sorbent assay for antibodies to a shared MCF virus antigen.

10 ter in vitro stimulation with purified whole virus antigens.

11 avirus-specific T cells cross-recognising JC virus antigens.

12 as well as durable human immune responses to virus antigens.

13 etric mean antibody titer to human influenza virus antigens.

14 phocytic choriomeningitis virus and vaccinia virus antigens.

15 cy virus type 1 (HIV-1) and type A influenza virus antigens.

16 en the vaccine immunogen and the encountered virus antigens.

17 o cytomegalovirus and human immunodeficiency virus antigens.

18 c disease without the introduction of animal virus antigens.

19 eimer's disease to two separate Epstein-Barr virus antigens.

20 elicited by previous exposures to influenza virus antigens(4).

21 risons of similar doses of a novel influenza virus antigen administered by the intradermal route and

22 Taken together, Lassa virus antigen and IgM ELISAs were 88% (95% confidence in

23 nked immunosorbent assays (ELISAs) for Lassa virus antigen and immunoglobulin M (IgM) and G (IgG) ant

24 on; cases were confirmed by the detection of virus antigen and nucleic acid in blood, cell culture, a

25 in situ hybridization, intense Cache Valley virus antigen and RNA staining was detected in the brain

26 TA1 enhanced immune responses to inactivated virus antigen and subsequent protection against H1N1 flu

27 confirmed the colocalization of internalized virus antigen and the endosomal marker dynamin.

28 Antibody isotype responses to virus antigens and cytokine production were monitored by

29 Virus antigens and RNA were localized to the brains (cor

30 Lassa fever virus antigens and viral particles were observed in mult

31 terologous (inactivated vesicular stomatitis virus) antigens and acceptable accuracy/linearity of WHO

32 y responses, and levels of infectious virus, virus antigen, and virus RNA were similar in both groups

33 lve attempts to suppress immune responses to virus antigens, and re-targeting of viruses to favor tum

34 or the presence of antibodies to hepatitis C virus antigen (anti-HCV), hepatitis B surface antigen (H

35 Paradoxically, virus antigens are largely focused in the epithelial lay

36 sally with rM51R vectors expressing vaccinia virus antigens B5R and L1R were protected against lethal

37 se all known regulatory B subunits, or tumor virus antigens, bind stably only to the AC dimer of PP2A

38 rus infectivity was assessed by detection of virus antigen by flow cytometry together with various he

39 ected American crows was also examined by WN virus antigen capture immunoassay and TaqMan for the pre

40 The recommended WN virus antigen capture protocol, which includes a capture

41 rsensitivity (DTH) response upon intradermal virus antigen challenge.

42 ntibodies or lymphocyte proliferation to the virus antigen (class II MHC immune functions).

43 y protects against ME/CFS via elimination of virus antigens; conversely, weak HLA-antigen binding may

44 rated by continued tdTomato expression after virus antigen could no longer be detected.

45 only hemagglutinin but also other influenza virus antigens could form the basis for a universal infl

46 e Directigen and VIDAS respiratory syncytial virus antigen detection assays with viral culture, the s

47 Histopathologic changes corresponded with virus antigen distribution, being largely limited to nas

48 h levels of immune cells harboring influenza virus antigen during viral infection and cell-type-speci

49 pH1N1 virus antigen elicited stronger cross-reactive memory B

50 iated immunity to two human immunodeficiency virus antigens, Env and Nef, have been examined in mice.

51 haracterized by a combination of the Grimsby virus antigen enzyme-linked immunosorbent assay, reverse

52 adherence provided an important trigger for virus antigen expression.

53 yelination correlated with the appearance of virus antigen expression.

54 s replicate well enough to supply sufficient virus antigen for demand.

55 c indirect ELISAs utilizing infectious-based virus antigens for detection of virus-specific IgG antib

56 s macaques results in SVV reactivation, with virus antigens found in zoster rash and SVV DNA and anti

57 method for the detection of bovine leukemia virus antigen gp51.

58 was applied to the detection of Hepatitis B virus antigen (HBsAg) in human blood plasma.

59 no acid substitutions in the major influenza virus antigen hemagglutinin (HA).

60 ccines that contain four influenza A group 2 virus antigens (hemagglutinin stalk, neuraminidase, matr

61 lycosylation patterns of the major influenza virus antigen, hemagglutinin (HA).

62 uito pools (n = 100), this assay detected WN virus antigen in 12 of 18 (66.7%) TaqMan-positive pools,

63 The presence of West Nile virus antigen in fixed cells or cell lysates was reveale

64 ith T3 reovirus strains and colocalizes with virus antigen in individual neurons.

65 capture immunoassay to detect West Nile (WN) virus antigen in infected mosquitoes and avian tissues h

66 re associated with the presence of influenza virus antigen in parenchymal, not endothelial cells.

67 uccessfully applied for the detection of the virus antigen in spiked nasal samples showing excellent

68 respiratory syncytial virus and influenza A virus antigens in clinical specimens.

69 infection on the presentation of hepatitis C virus antigens in cultured chimpanzee cells were examine

70 The immunolocalization of Lassa fever virus antigens in fatal cases provides novel insightful

71 Immunohistochemistry identified West Nile virus antigens in the brainstem and spinal cord.

72 ally due to lack of data on the detection of virus antigens in tissues.

73 Titers to avian influenza virus antigens increased with age and with geometric mea

74 a cells induced to express late Epstein-Barr virus antigens indicated that expression of BZLF2 did no

75 While the majority of virus antigen is detected in central nervous system macr

76 response during the peak of infection, when virus antigen is maximal.

77 Virus antigen levels within the kidney were highest in d

78 ratory-produced purified measles virus whole-virus antigen MBA (MeV WVA(L)) correlated better with EL

79 Evolution of influenza virus antigens means that vaccines must be updated to ma

80 Therefore, a commercially produced whole-virus antigen (MeV WVA(C)) was evaluated.

81 s with chronic HBV infection, high levels of virus antigens might prevent induction of HBV-specific i

82 with a DNA vaccine encoding immunodeficiency virus antigens mixed with ligands for TLR9 or TLR7/8.

83 ession studies in virus antigen-positive and virus antigen-negative live cells in the lungs of Color-

84 Clearance of virus antigen occurred preferentially from the gray matt

85 -2 ORF3a, N, and S proteins as well as whole virus antigens of the four major S1-genotypes 4/91, IS/1

86 Detection of Ebola virus antigens or virus isolation appears to be the most

87 vel form of rACE2, fused to the Epstein-Barr virus antigen P18F3 (rACE2-P18F3), to reorient a preexis

88 pect this protocol to take 2-3 d to complete virus antigen pattern identification from existing cryog

89 for differential gene expression studies in virus antigen-positive and virus antigen-negative live c

90 re paralyzed and had increased inflammation, virus antigen-positive cells, and TMEV-specific lymphopr

91 Furthermore, our data suggest that influenza virus antigens prepared via systems not reliant on egg a

92 tant, containing high-titered recombinant WN virus antigen, proved to be an excellent alternative to

93 CD39 levels compared to bystander bulk- and virus-antigen reactive CD8(+) T cells.

94 n retrieval methods to determine the optimal virus antigen recovery as well as identifying alternativ

95 These findings indicate that high titers of virus antigens reduce the efficacy of therapeutic vaccin

96 lso tested both heat- and enzymatic-mediated virus antigen retrieval methods to determine the optimal

97 of a monoclonal antibody, recombinant Mexico virus antigen (rMXV)-based IgM capture enzyme-linked imm

98 Based on lack of virus antigen shedding and disease induction, the murine

99 The duration of virus antigen shedding following infection was considera

100 was evaluated by (i) clinical findings, (ii) virus antigen shedding or infectious virus titers in the

101 and analyzed the activation and function of virus antigen-specific CD4+ T cells.

102 This TRM expansion precedes infiltration of virus antigen-specific CD8 T cells and is due to prolife

103 ocytes into Ccr2(-/-)Ccl2(-/-) mice impaired virus antigen-specific clearance.

104 Virus antigen-specific lymphoproliferation was vigorous

105 Rapidly expanded VIL are enriched in virus antigen-specificity and show an activated, polyfun

106 of CD8(+) T cells specific for two different virus antigens stimulated ex vivo using either autologou

107 (HA)-specific memory B cell responses after virus antigen stimulation in nose-associated lymphoid ti

108 show significant cross-reactivity with other virus antigens such as influenza A and HCoV, indicating

109 TL lines are used against genetically stable virus antigens, suggests that escape mutants may be a se

110 ccuracy of positive QuickVue rapid influenza virus antigen test results.

111 cted cells revealed a filamentous pattern of virus antigen, the appearance of which was sensitive to

112 imulation by overlapping peptide pools of BK virus antigen to determine frequency of CD8+ and CD4+ T

113 lan et al. conclude that transport of herpes-virus antigens to lymph nodes by dendritic cells is cruc

114 the more traditional suckling-mouse brain WN virus antigen used in the immunoglobulin M (IgM) antibod

115 e tested for antibodies to 5 avian influenza virus antigens, using a protein microarray.

116 The detection of the virus antigen was achieved via swabbing followed by comp

117 A multivalent Dengue virus antigen was designed and shown to bind antibodies

118 Rabies virus antigen was detected in archived autopsy brain tis

119 The low detection limit for Hepatitis B virus antigen was estimated to be 0.01IU/mL.

120 Varicella-zoster virus antigen was found in 45 of 70 GCA-negative TAs (64

121 In contrast, by immunohistochemistry virus antigen was found in liver, intestine, kidney, spl

122 Varicella-zoster virus antigen was frequently found in perineurial cells

123 Virus antigen was localized predominantly to anterior ho

124 Virus antigen was localized predominantly to anterior ho

125 Virus antigen was more abundant and infectious virus inc

126 Virus antigen was observed in airway epithelia, pneumocy

127 Virus antigen was partially controlled during the early

128 The virus antigen was prepared from the KS-1 cell line, whic

129 mbinant human monoclonal antibodies to Ebola virus antigens was isolated from phage display libraries

130 zoster antigen (also called varicella-zoster virus antigen) was detectable in temporal artery biopsie

131 ys using a new ELISA for EBO (subtype Zaire) virus antigen were conducted to assess the prevalence of

132 es virus neutralizing antibodies, and rabies virus antigens were conducted on available specimens, in

133 Respiratory syncytial virus antigens were detected in circulating CD4+ and CD8

134 ls directed against both cell- and egg-grown virus antigens, whereas egg-grown virus vaccine induced

135 r epithelium, with extensive distribution of virus antigen within tracheal, bronchial, bronchiolar, a

136 lded influenza H1N1 or respiratory syncitial virus antigens yielded reduced or unchanged reactivity i